230 related articles for article (PubMed ID: 32738587)
1. A conserved coccidian gene is involved in Toxoplasma sensitivity to the anti-apicomplexan compound, tartrolon E.
Bowden GD; Reis PM; Rogers MB; Bone Relat RM; Brayton KA; Wilson SK; Di Genova BM; Knoll LJ; Nepveux V FJ; Tai AK; Ramadhar TR; Clardy J; O'Connor RM
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():1-7. PubMed ID: 32738587
[TBL] [Abstract][Full Text] [Related]
2. A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity.
O'Connor RM; Nepveux V FJ; Abenoja J; Bowden G; Reis P; Beaushaw J; Bone Relat RM; Driskell I; Gimenez F; Riggs MW; Schaefer DA; Schmidt EW; Lin Z; Distel DL; Clardy J; Ramadhar TR; Allred DR; Fritz HM; Rathod P; Chery L; White J
PLoS Pathog; 2020 May; 16(5):e1008600. PubMed ID: 32453775
[TBL] [Abstract][Full Text] [Related]
3. The Marine Compound Tartrolon E Targets the Asexual and Early Sexual Stages of
Cotto-Rosario A; Miller EYD; Fumuso FG; Clement JA; Todd MJ; O'Connor RM
Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36422330
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 4-Amino 2-Anilinoquinazolines against
Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
[TBL] [Abstract][Full Text] [Related]
5. Tartrolon E, a secondary metabolite of a marine symbiotic bacterium, is a potent inhibitor of asexual and sexual
Chery-Karschney L; Patrapuvich R; Mudeppa DG; Kokkonda S; Chakrabarti R; Sriwichai P; O'Connor RM; Rathod PK; White J
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0068423. PubMed ID: 38193705
[TBL] [Abstract][Full Text] [Related]
6. TKL family kinases in human apicomplexan pathogens.
Ali DH; Gaji RY
Mol Biochem Parasitol; 2024 Sep; 259():111628. PubMed ID: 38719028
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of stage specific gene regulation of apicomplexan parasites: Plasmodium falciparum and Toxoplasma gondii.
Gopalakrishnan AM; López-Estraño C
Infect Disord Drug Targets; 2010 Aug; 10(4):303-11. PubMed ID: 20429866
[TBL] [Abstract][Full Text] [Related]
8. New and emerging uses of CRISPR/Cas9 to genetically manipulate apicomplexan parasites.
Di Cristina M; Carruthers VB
Parasitology; 2018 Aug; 145(9):1119-1126. PubMed ID: 29463318
[TBL] [Abstract][Full Text] [Related]
9. (31)P NMR of apicomplexans and the effects of risedronate on Cryptosporidium parvum growth.
Moreno B; Bailey BN; Luo S; Martin MB; Kuhlenschmidt M; Moreno SN; Docampo R; Oldfield E
Biochem Biophys Res Commun; 2001 Jun; 284(3):632-7. PubMed ID: 11396947
[TBL] [Abstract][Full Text] [Related]
10. Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum.
Li K; Grooms GM; Khan SM; Hernandez AG; Witola WH; Stec J
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():80-90. PubMed ID: 33011650
[TBL] [Abstract][Full Text] [Related]
11. RNG1 is a late marker of the apical polar ring in Toxoplasma gondii.
Tran JQ; de Leon JC; Li C; Huynh MH; Beatty W; Morrissette NS
Cytoskeleton (Hoboken); 2010 Sep; 67(9):586-98. PubMed ID: 20658557
[TBL] [Abstract][Full Text] [Related]
12. Systems-based analysis of the Sarcocystis neurona genome identifies pathways that contribute to a heteroxenous life cycle.
Blazejewski T; Nursimulu N; Pszenny V; Dangoudoubiyam S; Namasivayam S; Chiasson MA; Chessman K; Tonkin M; Swapna LS; Hung SS; Bridgers J; Ricklefs SM; Boulanger MJ; Dubey JP; Porcella SF; Kissinger JC; Howe DK; Grigg ME; Parkinson J
mBio; 2015 Feb; 6(1):. PubMed ID: 25670772
[TBL] [Abstract][Full Text] [Related]
13. Boromycin Has Potent Anti-
Abenoja J; Cotto-Rosario A; O'Connor R
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468470
[No Abstract] [Full Text] [Related]
14. Altiratinib blocks
Swale C; Bellini V; Bowler MW; Flore N; Brenier-Pinchart MP; Cannella D; Belmudes L; Mas C; Couté Y; Laurent F; Scherf A; Bougdour A; Hakimi MA
Sci Transl Med; 2022 Aug; 14(656):eabn3231. PubMed ID: 35921477
[TBL] [Abstract][Full Text] [Related]
15. In vitro cultivation methods for coccidian parasite research.
Feix AS; Cruz-Bustos T; Ruttkowski B; Joachim A
Int J Parasitol; 2023 Aug; 53(9):477-489. PubMed ID: 36400306
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasma gondii: the model apicomplexan.
Kim K; Weiss LM
Int J Parasitol; 2004 Mar; 34(3):423-32. PubMed ID: 15003501
[TBL] [Abstract][Full Text] [Related]
17. Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum.
Khan SM; Garcia Hernandez A; Allaie IM; Grooms GM; Li K; Witola WH; Stec J
Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():6-20. PubMed ID: 35462232
[TBL] [Abstract][Full Text] [Related]
18. Endocytosis in Plasmodium and Toxoplasma Parasites.
Spielmann T; Gras S; Sabitzki R; Meissner M
Trends Parasitol; 2020 Jun; 36(6):520-532. PubMed ID: 32340866
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.
Szajnman SH; Galaka T; Li ZH; Li C; Howell NM; Chao MN; Striepen B; Muralidharan V; Moreno SN; Rodriguez JB
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895021
[TBL] [Abstract][Full Text] [Related]
20. mRNA export in the apicomplexan parasite Toxoplasma gondii: emerging divergent components of a crucial pathway.
Ávila AR; Cabezas-Cruz A; Gissot M
Parasit Vectors; 2018 Jan; 11(1):62. PubMed ID: 29370868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
